SCHEMBL220323

SCHEMBL220323

[CH2]OCCOCCOC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4756763 1.00 CA2 (0.37)
SCHEMBL9347650 0.92 CA2 (0.33)
SCHEMBL2723 0.90
Ethylene SCHEMBL2428151 0.83 CA2 (0.41)
Ethylene SCHEMBL2956760 0.83 CA2 (0.41)
Ethylene SCHEMBL28434649 0.83 CA2 (0.41)
Ethylene SCHEMBL27414406 0.83 CA2 (0.41)
Ethylene SCHEMBL577873 0.83 CA2 (0.41)
SCHEMBL23647292 0.83 CA2 (0.44)
SCHEMBL11219700 0.83 CA2 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2030963-A2 Derivatives of 1-oxyl-4-hydroxy-or 4-amino-2,2,6,6-tetramethylpiperidine as polymerization inhibitors for (meth) acrylate monomers Ciba Holding Inc. (CH) 2009-03-04 EP claimed
EP-1095006-B1 DERIVATIVES OF 1-OXYL-4-HYDROXY-2,2,6,6-TETRAMETHYLPIPERIDINE AS POLYMERIZATION INHIBITORS FOR (METH) ACRYLATE MONOMERS CIBA HOLDING INC (CH) 2008-12-24 EP claimed
EP-1052968-B1 ALPHA-AMIDES OF(L)-AMINO ACIDS AS FRAGRANCE PRECURSORS GILLETTE CO (US) 2007-12-05 EP claimed
EP-1664023-A1 SUSTITUTED ISOQUINOLINE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2006-06-07 EP claimed
EP-1664027-A1 SUBSTITUTED 2,3-DIHYDRO-1H-ISOINDOL-1-ONE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2006-06-07 EP claimed
US-20050209195-A1 Indolinone derivatives CELL THERAPEUTICS EUROPE S.R.I (IT) 2005-09-22 US claimed
WO-2005068424-A1 INDOLINONE DERIVATIVES AS RECEPTOR TYROSINE KINASE IHIBITORS CELL THERAPEUTICS EUROPE S.R.L. (IT) 2005-07-28 WO claimed
WO-2005021533-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND METHODS OF USE AMGEN INC (US) 2005-03-10 WO claimed
WO-2005021532-A1 SUBSTITUTED 2,3-DIHYDRO-1H-ISOINDOL-1-ONE DERIVATIVES AND METHODS OF USE AMGEN INC (US) 2005-03-10 WO claimed
US-6861432-B2 Piperazine derivatives that destabilize androgen receptors SCHERING AKTIENGESELLSCHAFT (DE) 2005-03-01 US claimed
US-20040009969-A1 Piperazine derivatives that destabilize androgen receptors SCHERING AG (DE) 2004-01-15 US claimed
EP-1358184-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE Amgen Inc. (US) 2003-11-05 EP claimed
EP-1358161-A2 N-PYRIDYL CARBOXAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Amgen Inc. (US) 2003-11-05 EP claimed
WO-2002066470-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2002-08-29 WO claimed
WO-2002055501-A2 N-PYRIDYL CARBOXAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AMGEN INC (US) 2002-07-18 WO claimed
EP-1095006-A1 DERIVATIVES OF 1-OXYL-4-HYDROXY-OR 4-AMINO-2,2,6,6-TETRAMETHYLPIPERIDINE AS POLYMERIZATION INHIBITORS FOR (METH) ACRYLATE MONOMERS Ciba SC Holding AG (CH) 2001-05-02 EP claimed
US-6080864-A A STABILIZER PREVENTING THE PREMATURE POLYMERIZATION OF ACRYLIC AND METHACRYLIC ACIDS, THEIR ESTERS, THEIR AMIDES, VINYL ACETATE AND ACRYLONITRILE IN THE PRESENCE OF WATER CIBA SPECIALTY CHEMICALS CORPORATION (US) 2000-06-27 US claimed
WO-2000003965-A1 DERIVATIVES OF 1-OXYL-4-HYDROXY- OR 4-AMINO-2,2,6,6-TETRAMETHYLPIPERIDINE AS POLYMERIZATION INHIBITORS FOR (METH)ACRYLATE MONOMERS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-01-27 WO claimed
US-5932735-A STABILIZERS CIBA SPECIALTY CHEMICALS CORPORATION (US) 1999-08-03 US claimed
US-20170266336-A1 Colour-stable superabsorbent BASF SE (DE) 2017-09-21 US disclosed
EP-3037836-B1 ULTRASENSITIVE MAGNETIC SENSOR BASED ON GIANT FARADAY ROTATION TOYOTA MOTOR CO LTD (JP) 2017-09-13 EP disclosed
US-9494809-B2 Ultrasensitive magnetic sensor with magneto-optically active material with high verdet constant TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2016-11-15 US disclosed
EP-3037836-A1 ULTRASENSITIVE MAGNETIC SENSOR BASED ON GIANT FARADAY ROTATION Toyota Jidosha Kabushiki Kaisha (JP) 2016-06-29 EP disclosed
US-9284307-B2 Macrocyclic serine protease inhibitors IDENIX PHARMACEUTICALS LLC (US) 2016-03-15 US disclosed
EP-2380029-B1 ULTRASENSITIVE MAGNETIC SENSOR BASED ON GIANT FARADAY ROTATION TOYOTA MOTOR CO LTD (JP) 2015-10-21 EP disclosed
US-8993595-B2 Macrocyclic serine protease inhibitors IDENIX PHARMACEUTICALS, INC. (US) 2015-03-31 US disclosed
US-8920939-B2 Heteroatomic regioregular poly (3-substitutedthiophenes) in electroluminescent devices SOLVAY USA, INC. (US) 2014-12-30 US disclosed
CN-101828552-B Methods of blocking ethylene response in plants using cyclopropene derivatives UNIV NORTH CAROLINA STATE 2014-09-24 CN disclosed
US-20140070802-A1 ULTRASENSITIVE MAGNETIC SENSOR WITH MAGNETO-OPTICALLY ACTIVE MATERIAL WITH HIGH VERDET CONSTANT KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2014-03-13 US disclosed
US-8575927-B2 Ultrasensitive magnetic sensor with magneto-optically active material with high verdet constant TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2013-11-05 US disclosed
US-20130224147-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2013-08-29 US disclosed
US-8377962-B2 Macrocyclic serine protease inhibitors IDENIX PHARMACEUTICALS, INC. (US) 2013-02-19 US disclosed
EP-2461811-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX Pharmaceuticals, Inc. (US) 2012-06-13 EP disclosed
EP-2417134-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX Pharmaceuticals, Inc. (US) 2012-02-15 EP disclosed
US-20120001625-A1 ULTRASENSITIVE MAGNETIC SENSOR BASED ON GIANT FARADAY ROTATION KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2012-01-05 US disclosed
EP-2380029-A1 ULTRASENSITIVE MAGNETIC SENSOR BASED ON GIANT FARADAY ROTATION Toyota Jidosha Kabushiki Kaisha (JP) 2011-10-26 EP disclosed
EP-1805825-B1 HETEROATOMIC REGIOREGULAR POLY(3-SUBSTITUTED THIOPHENES) IN PHOTOVOLTAIC CELLS PLEXTRONICS INC (US) 2011-08-24 EP disclosed
CN-1450859-B Method for blocking ethylene response in plants using cyclopropene derivatives UNIV NORTH CAROLINA STATE 2011-08-03 CN disclosed
US-20110129443-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2011-06-02 US disclosed
WO-2011017389-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX PHARMACEUTICALS, INC. (US) 2011-02-10 WO disclosed
WO-2010118078-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2010-10-14 WO disclosed
US-20100260710-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2010-10-14 US disclosed
CN-101828552-A Method with the cyclopropene derivatives blocking ethylene response in plants UNIV NORTH CAROLINA STATE 2010-09-15 CN disclosed
US-7790979-B2 Heteroatomic regioregular poly(3-substitutedthiophenes) for photovoltaic cells PLEXTRONICS, INC. (US) 2010-09-07 US disclosed
WO-2010082932-A1 ULTRASENSITIVE MAGNETIC SENSOR BASED ON GIANT FARADAY ROTATION TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2010-07-22 WO disclosed
EP-1805826-B1 HETEROATOMIC REGIOREGULAR POLY(3-SUBSTITUTEDTHIOPHENES) IN ELECTROLUMINESCENT DEVICES PLEXTRONICS INC (US) 2010-03-24 EP disclosed
CN-100583485-C Photovoltaic cell containing hetero atom stereoregular poly (3-substituted thiophene) PRAXTONICS CORP 2010-01-20 CN disclosed
EP-2030963-A2 Derivatives of 1-oxyl-4-hydroxy-or 4-amino-2,2,6,6-tetramethylpiperidine as polymerization inhibitors for (meth) acrylate monomers Ciba Holding Inc. (CH) 2009-03-04 EP disclosed
EP-1095006-B1 DERIVATIVES OF 1-OXYL-4-HYDROXY-2,2,6,6-TETRAMETHYLPIPERIDINE AS POLYMERIZATION INHIBITORS FOR (METH) ACRYLATE MONOMERS CIBA HOLDING INC (CH) 2008-12-24 EP disclosed
EP-1259565-B1 SILICA REINFORCED RUBBER COMPOSITIONS OF IMPROVED PROCESSABILITY AND STORAGE STABILITY PIRELLI (IT) 2008-11-26 EP disclosed
EP-1971604-A2 PYRROLO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES Amgen Inc. (US) 2008-09-24 EP disclosed
WO-2008110612-A2 NOVEL COMPOUNDS AND LUBRICATING COMPOSITIONS COMPRISING THE SAME SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2008-09-18 WO disclosed
CN-100379724-C Inhibition of pulp and paper yellowing using nitroxides and other coadditives CIBA SC HOLDING AG (CH) 2008-04-09 CN disclosed
US-7321133-B2 Heteroatomic regioregular poly(3-substitutedthiophenes) as thin film conductors in diodes which are not light emitting or photovoltaic PLEXTRONICS, INC. (US) 2008-01-22 US disclosed
CN-101084588-A Heteroatomic regioregular poly (3-substitutedthiophenes) in electroluminescent devices PLEXTRONICS INC (US) 2007-12-05 CN disclosed
CN-101076901-A Photovoltaic cell containing hetero atom stereoregular poly (3-substituted thiophene) PRAXTONICS CORP (US) 2007-11-21 CN disclosed
EP-1805826-A1 HETEROATOMIC REGIOREGULAR POLY(3-SUBSTITUTEDTHIOPHENES) IN ELECTROLUMINESCENT DEVICES Plextronics, Inc. (US) 2007-07-11 EP disclosed
EP-1805825-A2 HETEROATOMIC REGIOREGULAR POLY(3-SUBSTITUTEDTHIOPHENES) IN PHOTOVOLTAIC CELLS Plextronics, Inc. (US) 2007-07-11 EP disclosed
WO-2007048070-A2 PYRROLO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES AMGEN INC. (US) 2007-04-26 WO disclosed
US-20060118901-A1 Heteroatomic regioregular poly(3-substitutedthiophenes) as thin film conductors in diodes whcih are not light emitting or photovoltaic PLEXTRONICS, INC. 2006-06-08 US disclosed
EP-1664023-A1 SUSTITUTED ISOQUINOLINE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2006-06-07 EP disclosed
EP-1664027-A1 SUBSTITUTED 2,3-DIHYDRO-1H-ISOINDOL-1-ONE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2006-06-07 EP disclosed
US-20060078761-A1 Heteroatomic regioregular poly (3-substitutedthiophenes) in electroluminescent devices PLEXTRONICS, INC. 2006-04-13 US disclosed
US-20060076050-A1 Heteroatomic regioregular poly(3-substitutedthiophenes) for photovoltaic cells PLEXTRONICS, INC. 2006-04-13 US disclosed
WO-2006036756-A2 HETEROATOMIC REGIOREGULAR POLY(3-SUBSTITUTEDTHIOPHENES) IN PHOTOVOLTAIC CELLS PLEXTRONICS, INC. (US) 2006-04-06 WO disclosed
WO-2006036755-A1 HETEROATOMIC REGIOREGULAR POLY(3-SUBSTITUTEDTHIOPHENES) IN ELECTROLUMINESCENT DEVICES PLEXTRONICS, INC. (US) 2006-04-06 WO disclosed
EP-1583744-A2 SUBSTITUTED BENZYLAMINE DERIVATIVES AND METHODS OF USE Amgen Inc. (US) 2005-10-12 EP disclosed
US-20050209195-A1 Indolinone derivatives CELL THERAPEUTICS EUROPE S.R.I (IT) 2005-09-22 US disclosed
EP-1562933-A2 SUBSTITUTED AMINE DERIVATIVES AND METHODS OF USE IN THE TREATMENT OF ANGIOGENESIS RELATED DISORDERS Amgen Inc. (US) 2005-08-17 EP disclosed
WO-2005068424-A1 INDOLINONE DERIVATIVES AS RECEPTOR TYROSINE KINASE IHIBITORS CELL THERAPEUTICS EUROPE S.R.L. (IT) 2005-07-28 WO disclosed
EP-1537084-A1 SUBSTITUTED 2-ALKYLAMINE NICOTINIC AMIDE DERIVATIVES AND USE THERE OF Amgen Inc. (US) 2005-06-08 EP disclosed
EP-1519921-A2 SUBSTITUTED ANTHRANILIC AMIDE DERIVATIVES AND METHODS OF USE Amgen Inc. (US) 2005-04-06 EP disclosed
WO-2005021533-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND METHODS OF USE AMGEN INC (US) 2005-03-10 WO disclosed
WO-2005021532-A1 SUBSTITUTED 2,3-DIHYDRO-1H-ISOINDOL-1-ONE DERIVATIVES AND METHODS OF USE AMGEN INC (US) 2005-03-10 WO disclosed
US-6861432-B2 Piperazine derivatives that destabilize androgen receptors SCHERING AKTIENGESELLSCHAFT (DE) 2005-03-01 US disclosed
US-6822037-B2 BLENDS CONTAINING SILICA AND ELASTOMER; TIRES; MELT PROCESSABILITY, STORAGE STABILITY PIRELLI PNEUMATICI S.P.A. (IT) 2004-11-23 US disclosed
EP-1467721-A2 SUBSTITUTED AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF ANGIOGENESIS Amgen Inc. (US) 2004-10-20 EP disclosed
US-6737466-B2 INCREASING CURE RATE BY INCLUDING AN EPOXY COMPOUND, AN ABIETYL COMPOUND, STYRENATED RESORCINOL FORMALDEHYDE EPOXY POLYMER COMPOUND, OR AN ESTER HYDROXYL COMPOUND OF A MOLECULAR WEIGHT BELOW 7,000 PIRELLI PNEUMATICI S.P.A. (IT) 2004-05-18 US disclosed
EP-1233669-B1 BLOCKING AN ETHYLENE RESPONSE IN PLANTS USING CYCLOPROPENE DERIVATIVES UNIV NORTH CAROLINA STATE (US) 2004-02-25 EP disclosed
WO-2004007458-A1 SUBSTITUTED 2-ALKYLAMINE NICOTINIC AMIDE DERIVATIVES AND USE THERE OF AMGEN INC. (US) 2004-01-22 WO disclosed
WO-2004007457-A2 SUBSTITUTED BENZYLAMINE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2004-01-22 WO disclosed
WO-2004007481-A2 SUBSTITUTED AMINE DERIVATIVES AND METHODS OF USE IN THE TREATMENT OF ANGIOGENESIS RELATES DISORDERS AMGEN INC. (US) 2004-01-22 WO disclosed
WO-2004005279-A2 SUBSTITUTED ANTHRANILIC AMIDE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2004-01-15 WO disclosed
US-20040009969-A1 Piperazine derivatives that destabilize androgen receptors SCHERING AG (DE) 2004-01-15 US disclosed
EP-1358184-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE Amgen Inc. (US) 2003-11-05 EP disclosed
EP-1358161-A2 N-PYRIDYL CARBOXAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Amgen Inc. (US) 2003-11-05 EP disclosed
CN-1450859-A method for blocking ethylene response in plants using cyclopropene derivatives UNIV NORTH CAROLINA STATE (US) 2003-10-22 CN disclosed
US-20030158317-A1 Silica reinforced rubber compositions of improved processability and storage stability PIRELLI PNEUMATICI S.P.A. (IT) 2003-08-21 US disclosed
EP-0815833-B1 Malodour preventing agents GIVAUDAN SA (CH) 2003-04-09 EP disclosed
US-6500983-B2 FOR THERAPY OF DISEASES OR CONDITIONS MEDIATED BY OVER-PRODUCTION OF OR OVER-RESPONSIVENESS TO TUMOR NECROSIS FACTOR (TNF) NOVARTIS AG (CH) 2002-12-31 US disclosed
US-6482884-B1 Silica reinforced rubber compositions of improved processability and storage stability PIRELLI PNEUMATICI S.P.A. (IT) 2002-11-19 US disclosed
WO-2002068406-A2 SUBSTITUTED AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF ANGIOGENESIS AMGEN INC. (US) 2002-09-06 WO disclosed
WO-2002066470-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2002-08-29 WO disclosed
WO-2002055501-A2 N-PYRIDYL CARBOXAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AMGEN INC (US) 2002-07-18 WO disclosed
EP-0929517-B1 HYDROXAMIC ACID DERIVATIVES NOVARTIS AG (CH) 2002-06-12 EP disclosed
US-20020038045-A1 Hydroxamic acid derivatives NOVARTIS AG (CH) 2002-03-28 US disclosed
EP-1095006-A1 DERIVATIVES OF 1-OXYL-4-HYDROXY-OR 4-AMINO-2,2,6,6-TETRAMETHYLPIPERIDINE AS POLYMERIZATION INHIBITORS FOR (METH) ACRYLATE MONOMERS Ciba SC Holding AG (CH) 2001-05-02 EP disclosed
US-6159973-A Aromatic amides, their preparation process, the compositions containing them and their use as pesticides HOECHST SCHERING AGREVO S.A. (FR) 2000-12-12 US disclosed
US-6150542-A COSMETICS; IN DEODORIZERS, ANTIPERSPIRANTS GIVAUDAN ROURE (INTERNATIONAL) SA (CH) 2000-11-21 US disclosed
CN-1270580-A Inhibition of pulp and paper yellowing using nitroxides and other coadditives CIBA SC HOLDING AG (CH) 2000-10-18 CN disclosed
US-6080864-A A STABILIZER PREVENTING THE PREMATURE POLYMERIZATION OF ACRYLIC AND METHACRYLIC ACIDS, THEIR ESTERS, THEIR AMIDES, VINYL ACETATE AND ACRYLONITRILE IN THE PRESENCE OF WATER CIBA SPECIALTY CHEMICALS CORPORATION (US) 2000-06-27 US disclosed
EP-1000032-A1 INHIBITION OF PULP AND PAPER YELLOWING USING NITROXIDES AND OTHER COADDITIVES Ciba SC Holding AG (CH) 2000-05-17 EP disclosed
WO-2000003965-A1 DERIVATIVES OF 1-OXYL-4-HYDROXY- OR 4-AMINO-2,2,6,6-TETRAMETHYLPIPERIDINE AS POLYMERIZATION INHIBITORS FOR (METH)ACRYLATE MONOMERS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-01-27 WO disclosed
US-6013837-A E.G.,4-(2-(3,4,5-TRICHLORO PHENYL) 1-FLUOROCYCLOPROPYL)-N-(2-METHYL PHENYL)BENZAMIDE; PARTICULAR USE AGAINST ARTHROPODS, HELMINTHS AND MOLLUSCS; INSECTICIDES; ACARICIDES; NEMATICIDES; PHOTOSTABILITY; NONTOXIC TO MAMMALS HOECHST MARION ROUSSEL (FR) 2000-01-11 US disclosed
US-5932735-A STABILIZERS CIBA SPECIALTY CHEMICALS CORPORATION (US) 1999-08-03 US disclosed
EP-0929517-A1 HYDROXAMIC ACID DERIVATIVES Novartis AG (CH) 1999-07-21 EP disclosed
US-5925339-A ODORLESS DEODORANTS AND ANTIPERSPIRANTS GIVAUDAN ROURE SA (CH) 1999-07-20 US disclosed
WO-1999005108-A1 INHIBITION OF PULP AND PAPER YELLOWING USING NITROXIDES AND OTHER COADDITIVES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 1999-02-04 WO disclosed
WO-1998014424-A1 HYDROXAMIC ACID DERIVATIVES NOVARTIS AG (CH) 1998-04-09 WO disclosed
EP-0815833-A2 Malodour preventing agents GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) 1998-01-07 EP disclosed
EP-0349991-B1 Process for producing vitamin A or its carboxylic acid esters KURARAY CO (JP) 1994-05-11 EP disclosed
US-4942262-A Process for producing vitamin A or its carboxylic acid esters KURARAY COMPANY LTD. (JP) 1990-07-17 US disclosed
EP-0349991-A2 Process for producing vitamin A or its carboxylic acid esters KURARAY CO., LTD. (JP) 1990-01-10 EP disclosed
EP-0176076-B1 METHOD FOR THE PREPARATION OF CROWN ETHERS Consortium für elektrochemische Industrie GmbH (DE) 1988-09-14 EP disclosed
EP-0176076-A1 Method for the preparation of crown ethers Consortium für elektrochemische Industrie GmbH (DE) 1986-04-02 EP disclosed
EP-0144290-A2 Substituted ethylenediamine derivatives CIBA-GEIGY AG (CH) 1985-06-12 EP disclosed
EP-0144290-A2 Substituted ethylenediamine derivatives CIBA-GEIGY AG (CH) 1985-06-12 EP disclosed